Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediBioSense is a UK-based healthcare innovation company specializing in medically certified wearable technologies and integrated digital health solutions. Founded in 2015, the company provides clinical-grade sensors such as the VitalPatch, MBS Infinity Watch, and MBS LifeStone for real-time monitoring of vital signs including ECG, heart rate, respiration, and blood oxygen. Its proprietary cloud-based platform, MBS HealthStream, enables healthcare providers to remotely track patient data, detect arrhythmias, and manage chronic conditions. MediBioSense serves a global clientele across more than 40 countries, including major hospitals, pharmaceutical companies, and government agencies like the US Department of Defense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediBioSense.